Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.

The proposed PSS for PA will enable more focused and cost-effective use of ARR screening and confirmatory testing. In our cohort, 40% and 42% of patients would not require ARR screening or confirmatory tests, respectively.